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Abstract
Background: Tissue plasminogen activator (t-PA) is a protein involved in the fibrinolytic
system that catalyzes the conversion of plasminogen into the active plasmin. The
activity of t-PA is controlled by plasminogen activator inhibitor-1. t-PA has crucial
functions during spermatogenesis. One polymorphism was reported for t-PA gene,
either the presence of a 300-bp Alu-repeat (Alu+) or its absence (Alu−).
Objective: The current work aimed at studying the association between Alu
polymorphism in the t-PA gene and male infertility.
Materials and Methods: Using polymerase chain reaction on genomic DNA isolated
from the blood of 79 participants, a region polymorphic for Alu element insertion in
t-PA gene was amplified. In addition, total t-PA concentration, plasminogen activator
inhibitor-1 /t-PA complex concentration, and t-PA activity in seminal plasma were
measured by enzyme-linked immunosorbent assay.
Results: The results indicate that the percentage of infertile participants (n = 50) who
were homozygous for t-PA Alu insertion (Alu+/+), heterozygous Alu+/− or homozygous
for t-PA Alu deletion (Alu−/−) did not change significantly (p = 0.43, 0.81, and 0.85,
respectively) when compared with the control participants (n = 29). On the other hand,
a significant decrease (p = 0.0001) of t-PA total concentration in seminal plasma was
observed in the infertile group in comparison with the control group. However, the
results indicate that there is no association between the t-PA Alu different genotypes
and the total t-PA seminal concentration in the infertile group when compared to the
control group (p = 0.63).
Conclusion: Data obtained from the current study does not support an association
between t-PA Alu polymorphism and t-PA seminal concentration or male infertility.
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1. Introduction
The male reproductive system consists of
several organs that work together to produce
sperm and other components of the semen (1).
The seminiferous tubules are lined with epithelial
cells that contain spermatogonial stem cells, which
develop into healthy sperm, and Sertoli cells (2).
In addition, the testes contain Leydig cells that
secrete testosterone (3).
The primary hormones involved in the male
reproductive system are testosterone, luteinizing
hormone, and follicle-stimulating hormone.
Testosterone is responsible for the development
of male characteristics and regulates the gene
expression or activates signaling pathways
in Sertoli cells that are required to maintain
spermatogenesis. Luteinizing hormone stimulates
the production of testosterone by Leydig cells, and
follicle-stimulating hormone is necessary to induce
Sertoli cells to secrete androgen binding-protein
(4-8).
Infertility is defined as the inability of couples
in reproductive age to achieve pregnancy
after one year of unprotected intercourse.
Worldwide, approximately 10-15% of couples
are considered infertile. According to the World
Health Organization (WHO), male factors are
diagnosed in almost 50% of infertility cases, either
solely (20%) or in combination with female factor
(30-40%) (9-12).
Sertoli cells play critical roles during
spermatogenesis by providing optimal
environment for germ cell development as well
phagocytosing residual bodies shed by developing
germ cells (13).
In addition, Sertoli cells are responsible for
secreting tissue plasminogen activator (t-PA) (14-15).
t-PA is a protein involved in the fibrinolytic system
that converts plasminogen, an inactive proenzyme,
into the active protease plasmin that dissolves
fibrin clot. The extracellular proteolysis mediated
by plasminogen activators (PA) is associated
with many important biological processes such
as tissue remodeling, tissue destruction, and
cell migration, in addition to some reproductive
events such as ovulation, luteolysis, and embryo
implantation. The activity of t-PA is controlled
by plasminogen activator inhibitor-1 (PAI-1), which
regulates t-PA activity by binding to t-PA’s active
site, preventing the formation of plasmin (16-
18).
In the human genome, t-PA is located at
chromosome 8p12-p11.2 (19). Many studies on
human population have indicated a 300-bp Alu
repeat sequence insertion within intron 8 of
the t-PA gene (20-23). One polymorphism was
reported for this Alu repeat; either the presence
of this repeat (Insertion/Alu+) or its absence
(Deletion/Alu−) (21). The Alu polymorphism
in the t-PA gene might play a role in the
primary structure of the protein, and it may
affect its secretion rate or plasma level (22).
It was reported that there is an association
between Alu polymorphism in the t-PA gene
and t-PA plasma levels (23). However, the
plasma level of t-PA is not only dependent
on the secretion of t-PA but also on its rate
and degree of complex-formation with PAI-
1 (23). During spermatogenesis, t-PA has a
role in the transport of preleptotene primary
spermatocytes, through the blood-testis barrier,
from the basal to the adluminal compartments
of the seminiferous tubules. In addition, t-
PA is involved during spermiation (14-15, 24-
26). However, and as far as our knowledge
is concerned, the association between t-PA
Alu polymorphism and spermatogenesis has
not been established. Thus, the current study
aimed at studying the association between
Alu polymorphism in the t-PA gene and male
infertility.
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2. Materials and Methods
2.1. Study population
The current study was a case-control study
conducted between May and December 2018.
A total of 79 Jordanian males consulting
gynecologists at different assisted reproduction
centers in Amman, Jordan were recruited to
participate in the current study. Patients were
identified from patient’s registry at the centers. All
included participants signed a consent form.
2.2. Sample collection
Blood samples were collected in EDTA blood
collection tubes and seminal fluid samples were
collected in sterile cups and were handled
according to the WHO guidelines (27). Seminal
fluid analysis (SFA) was performed according to
the WHO guidelines (27).
2.3. Alu polymorphism
Genomic DNA was extracted from blood
samples of control and infertile men using a
commercial genomic DNA purification kit (Wizard
Genomic DNA Purification Kit, Promega, USA).
DNA amplification by polymerase chain reaction
(PCR) in a thermal cycler (MyCycler, Bio-Rad,
USA) was performed following these conditions:
initial denaturation for 2 min at 96°C, followed
by 35 cycles of denaturation for 30 sec at 96°C,
annealing for 30 sec at 65°C and elongation
for 30 sec at 96°C. The total volume of each
reaction was 30 µl containing 1 µl of each forward
(GTAACCATTTAGTCCTCAGCTGTTCTCCT) and
reverse (CCATGTAAGAGTAGAAGGAGACTCAG-
TCA) primers (28), 8 µl of nuclease-free water, 15
µl of the master mix (New England Biolabs, USA),
and 5 µl of DNA sample.
PCR products were separated on 2% agarose
gel electrophoresis containing 0.5 µg/ml ethidium
bromide. Homozygote individuals carrying the t-PA
Alu inserts are designated Alu+/+, heterozygotes as
Alu+/−, and homozygotes for the absence of the
insert as Alu−/−.
2.4. t-PA concentration and activity
Seminal total t-PA concentration was measured
using the Human Total t-PA ELISA Kit (Assaypro
LLC, USA). The absorbance on a microplate reader
(Synergy HTX Multi-Mode Reader, USA) at a 450
nm was read immediately. On the other hand,
seminal PAI-1/t-PA concentration was measured
using the Human PAI-1/t-PA ELISA Kit (Assaypro
LLC, USA). The activity of seminal t-PA was assayed
using the Human t-PA Chromogenic Activity Kit
(Assaypro LLC, USA). The absorbance was read at
405 nm for a zero-minute background reading and
then was read every 1 hr on a microplate reader
(Synergy HTX Multi-Mode Reader, USA) for 6 hr.
2.5. Ethical consideration
The study was approved by the Institutional
Review Board (IRB) of the Hashemite University,
which conforms to the World Medical Association
Declaration of Helsinki (code: KTB/16/11/1800801).
2.6. Statistical analysis
All genotypes and frequencies for the insertion
or deletion of the recruited individuals were
calculated according to the counting method.
The observed genotypes and alleles frequencies
were compared with those expected in order
to verify the Hardy-Weinberg equilibrium. To
determine the differences between the two
means, the Student’s t test was performed, while
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the difference between the two proportions was
calculated using the two-proportion test. Factorial
ANOVA for higher orders (2-way or 3-way) was
used to test for interactive effects for multiple
categorical independent variables. Statistical
analysis was performed using the Statistica
software, StatSoft Inc., Tulsa, OK, USA (version
10). P-value < 0.05 was considered statistically
significant.
3. Results
Seminal fluid was collected from the 79
participants and analyzed. Twenty-nine samples
were normal (29.8 ± 4.3 yr) according to the WHO
criteria (27), while fifty samples were considered as
abnormal (36.7 ± 6.7 yr; Table I).
The Alu element of the t-PA gene was
successfully amplified from all genomic DNA
samples and PCR products were examined using
2% w/v agarose gel electrophoresis (Figure
1). Alu genotypes and allelic frequency of Alu
insertion/deletion of the t-PA gene in control and
infertile participation are shown in Table II. The
results indicated that the percentage of infertile
participants who were homozygotes for Alu+/+
was slightly decreased (66%) compared to the
control group (75.9%); however, this decrease
was insignificant (p = 0.43). On the other hand,
the percentage of both Alu−/− homozygotes
and heterozygotes Alu+/− were insignificantly
increased in the infertile group (16%, and 18%,
respectively) when compared to the control group
(10.3% and 13.8%, respectively) (p = 0.81, and 0.85,
respectively). The allelic frequency of the Alu−
was decreased for the infertile group (0.74) when
compared to the control group (0.81), though the
decrease was insignificant (p = 0.48).
Total t-PA concentration, PAI-1/t-PA complex
concentration, and t-PA activity in seminal plasma
were assessed by ELISA assay for the control and
infertile groups (Table III). The results show that the
total seminal t-PA (free and complexed with PAI-
1) was significantly lower in the infertile group in
comparison to the control group (p = 0.0001, Table
III). On the other hand, the concentration of seminal
t-PA complexed with PAI-1 in the infertile group
was higher than the control group; however, this
increase was insignificant (p = 0.19). The decrease
in concentration of total seminal t-PA and the
increase in t-PA/PAI-1 reflected in reduced activity
of t-PA in the infertile group, though this reduction
was insignificant (p = 0.68, Table III).
In order to assess if there was an association
between Alu polymorphism in the t-PA gene and
the total t-PA concentration in seminal plasma,
multifactorial ANOVA test was performed. The
results shown in Table IV indicate that the
total t-PA concentration in the three t-PA Alu
genotypes of the infertile group was lower
than those of the control group. However,
the statistical analysis of the results indicate
that there was no association between the
different t-PA Alu genotypes and the total t-PA
seminal concentration in the infertile group when
compared to the control group (p = 0.63, Table
IV).
Table I. Seminal fluid analysis of the 79 Jordanian male participants






Control 29 (36.7) 75.0 ± 27.2 33.7 ± 3.2 62.8 ± 9.0 5.3 ± 2.0
Infertile 50 (63.3) 30.4 ± 26.0 4.3 ± 5.3 31.5 ± 14.0 1.6 ± 0.8
Note: Data are expressed as Mean ± SD; n, sample size
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Table II. Alu genotypes and allelic frequency of t-PA gene in control and infertile participants
Genotype Control group % (n) Infertile group % (n) P-value 95% Confidence interval (CI)
Alu+/− 75.9% (22) 66% (33) 0.4327 -15 to 31.4
Alu+/− 10.3% (3) 16% (8) 0.8107 -49 to 41.6
Alu+/+ 13.8% (4) 18% (9) 0.8514 -45.4 to 39.1
Allele Control group (n = 29) Infertile group (n = 50)
Alu− 0.81 0.74 0.4789 -13.2 to 24
Alu+ 0.19 0.26 0.4789 -13.2 to 24
Note: Data are expressed as percentage; P-value of infertile group compared to that of the control group (two-proportion test)
Table III. Total t-PA concentration and activity in seminal plasma of control and infertile groups
Control group n = 29 Infertile group n = 50 P-value 95% Confidence interval (CI)
Total t-PA concentration (ng/ml) 28.6 ± 17.5 14.0 ± 7.8 0.0001 8.9 to 20.3
PAI-1/t-PA concentration (ng/ml) 1.6 ± 0.7 1.9 ± 1.1 0.1908 -0.75 to 0.15
t-PA activity (IU/ml) 72.5 ± 24.3 70.1 ± 25.7 0.6844 -9.3 to 14.1
Note: Data are expressed as Mean ± SD; P-value of the infertile group compared to that of the control group (the Student’s t
test)
Table IV. Total t-PA concentration in seminal plasma for t-PA Alu genotypes in control and infertile groups
Alu−/− Alu+/− Alu+/+





28.10 ± 18.53 13.9 ± 8.7 25.70 ± 2.01 15.6 ± 5.9 33.44 ± 19.85 13.1 ± 5.6 0.6342
Note: Data are expressed as Mean ± SD; P-value of the infertile group (n = 50) compared to that of the control group (n = 29)
(factorial ANOVA for higher orders)
Figure 1. Representative amplified Alu segment of the t-PA gene showing insertion (Alu+/+) and/or deletion (Alu−/−) of the segment.
Lane 1:100 bp Ladder; Lanes 2 and 3: Alu deletion (Alu−/−) at 300 bp; Lane 4: Alu insertion (Alu+/+) at 600 bp; Lanes 5 and 6: Alu
insertion and deletion (Alu+/−) at 300 bp and 600 bp.
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4. Discussion
In the current study, total t-PA concentration,
PAI-1/t-PA complex concentration, and t-PA activity
in seminal plasma for control and infertile groups
were determined (Table III). The results show that
the total seminal t-PA (free and complexed with
PAI-1) was significantly lower in the infertile group
in comparison with the control group (p = 0.0001,
Table III). On the other hand, the concentration of
seminal t-PA complexed with PAI-1 in the infertile
group was higher than the control group; however,
this increase was statistically insignificant (p = 0.19).
The decrease in the concentration of the total
seminal t-PA and the increase in the t-PA/PAI-1 were
reflected in reduced activity of t-PA in the infertile
group, although this reduction was insignificant (p
= 0.68; Table III).
t-PA is a protein involved in the fibrinolytic
system that converts the proenzyme plasminogen
into the active protease plasmin that dissolves
fibrin clot (17, 18). In addition, the extracellular
proteolysis mediated by t-PA is associated with
many important biological processes, such as
tissue remodeling, tissue destruction, and cell
migration. The activity of t-PA is controlled by PAI-1
(17, 18).
t-PA has been implicated in many diseases
such as thrombotic disorders including strokes and
myocardial infarction (29). In addition, it was found
to be involved in the process of angiogenesis in
cancer cells (30). Its concentration was reported
to be increased in breast cancer and myocardial
infarction patients. Furthermore, it has also been
associated with polycystic ovary syndrome (PCOS)
(29). Moreover, it was postulated that it has a role
during spermatogenesis. Sertoli cells-secreted t-PA
plays a role in the transport of preleptotene primary
spermatocytes, through the blood-testis barrier,
from the basal to the adluminal compartments of
the seminiferous tubules. In addition, t-PA was also
shown to play a role in the process of spermiation
at stages IX-XII (14, 15, 24-26).
It was reported that the limiting factor of how
much active t-PA is available in an organ is the
capacity of the organ endothelium to increase
its secretion of t-PA when required, that is, the
major physiological regulator of local (organ level)
fibrinolytic capacity is the secretion rate of t-PA (16,
18).
A single study reported the relation of t-
PA concentration with male infertility. A higher
concentration of t-PA was found in normal male
compared with oligo/azoospermia patients. In
addition, a higher number of immotile spermatozoa
in the semen was associated with higher t-PA
activities (31). The results presented in the current
study is in accordance with their results in terms of
concentration, but not activity (Table III). A possible
explanation for the lower t-PA concentration could
be due to the malfunction of the Sertoli cells, which
it is the source of t-PA in the testis (14, 15, 24-
26). However, testing this hypothesis is beyond the
scope of this work.
Alu DNA fragment is a major driving force for
evolution. The Alu element affects genes either
negatively via inactivation of genes or positively
by altering their function (32). The Alu (I/D) t-PA
polymorphism occurs in intron 8 of the t-PA gene
and consists of the presence (insertion; I or +) or
absence (deletion; D or -) of Alu fragment. The
three t-PA Alu genotypes are Alu+/+, Alu−/−, and
the heterozygote genotype Alu+/− (21). A genetic
polymorphism may affect the primary structure
of a protein, but may also affect its synthetic
rate or its plasma level if the protein involved
is a secretory protein. However, several studies
reported that Alu (I/D) polymorphism in t-PA locus
gene does not affect the synthesis rate of t-PA
(33, 34). Nevertheless, one study reported that
homozygous carriers of Alu (I/I) t-PA polymorphism
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have an increased “in vivo” release rate of t-PA
from vascular endothelial cells, even though this
polymorphism is located in a non-coding area of
the t-PA gene (22).
In the current study, the association between the
total t-PA concentration and t-PA Alu genotypes
in the normal and infertile participants was
determined. The results indicate that there was
no association between the different t-PA Alu
genotypes and the total t-PA seminal concentration
in the infertile group when compared to the control
group (p = 0.63; Table IV). The small sample size of
the current study could be the reason behind this
insignificant association.
5. Conclusion
In conclusion, data obtained from the current
study does not support the presence of an
association between t-PA Alu polymorphism and t-
PA seminal concentration or male infertility.
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